Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Long-Term Debt Repayments (2016)

Microbot Medical's Long-Term Debt Repayments history spans 7 years, with the latest figure at $358318.0 for Q2 2016.

  • For the quarter ending Q2 2016, Long-Term Debt Repayments fell 86.69% year-over-year to $358318.0, compared with a TTM value of $1.4 million through Sep 2016, up 89.19%, and an annual FY2015 reading of $24168.0, changed N/A over the prior year.
  • Long-Term Debt Repayments for Q2 2016 was $358318.0 at Microbot Medical, down from $1.1 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $2.7 million in Q2 2015, with the low at -$3.0 million in Q4 2014.
  • Average Long-Term Debt Repayments over 5 years is $289608.1, with a median of $62260.5 recorded in 2012.
  • Year-over-year, Long-Term Debt Repayments tumbled 2023.34% in 2014 and then surged 18995.23% in 2016.
  • Tracing MBOT's Long-Term Debt Repayments over 5 years: stood at -$121083.0 in 2012, then dropped by 15.71% to -$140104.0 in 2013, then tumbled by 2023.34% to -$3.0 million in 2014, then soared by 100.22% to $6404.0 in 2015, then skyrocketed by 5495.22% to $358318.0 in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Long-Term Debt Repayments are $358318.0 (Q2 2016), $1.1 million (Q1 2016), and $6404.0 (Q4 2015).